132 related articles for article (PubMed ID: 49654)
1. Immunological basis for latency, recurrences and putative oncogenicity of herpes simplex virus.
Lehner T; Wilton JM; Shillitoe EJ
Lancet; 1975 Jul; 2(7924):60-2. PubMed ID: 49654
[TBL] [Abstract][Full Text] [Related]
2. Role of Fc receptors in herpes simplex virus infection.
Costa JC; Rabson AS
Lancet; 1975 Jan; 1(7898):77-8. PubMed ID: 46027
[TBL] [Abstract][Full Text] [Related]
3. Infection with herpes-simplex viruses 1 and 2. II.
Nahmias AJ; Roizman B
N Engl J Med; 1973 Oct; 289(14):719-25. PubMed ID: 4353782
[TBL] [Abstract][Full Text] [Related]
4. CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8
Srivastava R; Khan AA; Chilukuri S; Syed SA; Tran TT; Furness J; Bahraoui E; BenMohamed L
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468883
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
J Virol; 2017 May; 91(9):. PubMed ID: 28228587
[TBL] [Abstract][Full Text] [Related]
6. The continuing problem of herpes simplex virus persistence.
Rajcáni J; Szántó J
Acta Virol; 1983 Sep; 27(5):442-50. PubMed ID: 6139950
[TBL] [Abstract][Full Text] [Related]
7. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. II. Identification as a K cell.
Melewicz FM; Shore SL; Ades EW; Phillips DJ
J Immunol; 1977 Feb; 118(2):567-73. PubMed ID: 65428
[TBL] [Abstract][Full Text] [Related]
8. [Humoral and cell-mediated immunity in herpes simplex virus infection].
Eis-Hübinger AM; Schneweis KE
Monatsschr Kinderheilkd; 1991 Jul; 139(7):391-5. PubMed ID: 1656247
[TBL] [Abstract][Full Text] [Related]
9. Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus.
Zaia JA; Palmer EL; Feorino PM
J Infect Dis; 1975 Dec; 132(6):660-6. PubMed ID: 172562
[TBL] [Abstract][Full Text] [Related]
10. Direct evidence for antibody bipolar bridging on herpes simplex virus-infected cells.
Van Vliet KE; De Graaf-Miltenburg LA; Verhoef J; Van Strijp JA
Immunology; 1992 Sep; 77(1):109-15. PubMed ID: 1328043
[TBL] [Abstract][Full Text] [Related]
11. Immune interactions with cells infected with herpes simplex virus: antibodies to radioiodinated surface antigens.
Glorioso JC; Smith JW
J Immunol; 1977 Jan; 118(1):114-21. PubMed ID: 187696
[TBL] [Abstract][Full Text] [Related]
12. Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene "anti-sense" transcript by in situ hybridization.
Croen KD; Ostrove JM; Dragovic LJ; Smialek JE; Straus SE
N Engl J Med; 1987 Dec; 317(23):1427-32. PubMed ID: 2825014
[TBL] [Abstract][Full Text] [Related]
13. The cycle of human herpes simplex virus infection: virus transport and immune control.
Cunningham AL; Diefenbach RJ; Miranda-Saksena M; Bosnjak L; Kim M; Jones C; Douglas MW
J Infect Dis; 2006 Sep; 194 Suppl 1():S11-8. PubMed ID: 16921466
[TBL] [Abstract][Full Text] [Related]
14. Acute and latent infection of sensory ganglia with herpes simplex virus: immune control and virus reactivation.
Openshaw H; Asher LV; Wohlenberg C; Sekizawa T; Notkins AL
J Gen Virol; 1979 Jul; 44(1):205-15. PubMed ID: 227991
[TBL] [Abstract][Full Text] [Related]
15. Reactivation of herpes simplex virus (type 2) infection in trigeminal ganglia and oral lips with cyclophosphamide treatment.
Kurata T; Kurata K; Aoyama Y
Jpn J Exp Med; 1978 Oct; 48(5):427-35. PubMed ID: 219274
[TBL] [Abstract][Full Text] [Related]
16. Neuron to neuron transmission of herpes simplex virus. Transport of virus from skin to brainstem nuclei.
Kristensson K; Nennesmo L; Persson L; Lycke E
J Neurol Sci; 1982 Apr; 54(1):149-56. PubMed ID: 6281393
[TBL] [Abstract][Full Text] [Related]
17. Cellular immunity and circulating antibody to herpes simplex virus in subjects with recurrent herpex simplex lesions and controls as measured by the mixed leukocyte migration inhibition test and complement fixation.
Gange RW; de Bats A; Park JR; Bradstreet CM; Rhodes EL
Br J Dermatol; 1975 Nov; 93(5):539-44. PubMed ID: 173386
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex antigen in immune complexes of patients with erythema multiforme: presence following recurrent herpes simplex infection.
Kazmierowski JA; Peizner DS; Wuepper KD
JAMA; 1982 May; 247(18):2547-50. PubMed ID: 6279897
[TBL] [Abstract][Full Text] [Related]
19. Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein D.
Wachsman M; Aurelian L; Smith CC; Lipinskas BR; Perkus ME; Paoletti E
J Infect Dis; 1987 Jun; 155(6):1188-97. PubMed ID: 3033094
[TBL] [Abstract][Full Text] [Related]
20. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity in vivo.
Voss LM; David CS; Showalter SD; Paya CV; Leibson PJ
Int Immunol; 1992 Mar; 4(3):417-20. PubMed ID: 1314641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
